ENSGThe Ensign Group, Inc.
Is the price fair?
Neither cheap nor expensive: nothing decisive, though at the top of its own P/E range.
Expensive vs its own history: P/E 26.9 vs a 23.8 median over 41 quarters (+13% vs median).
Sector median 22.6× across 130 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What ENSG's price assumes
The Ensign Group, Inc. trades at 26.9× earnings against 20.0× for the median Medical Care Facilities name, more expensive than its own group.
Trailing P/E · Medical Care Facilities median 20.0 · 1.34× the median: the market pays up for this one
- Price / sales
- 1.77
Price / sales · today's price, trailing year to Jun 30, 2026
- Price / book
- 3.97
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 1.74
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 3.97
- EV / EBITtoday's price, trailing year to Jun 30, 2026
- 20.3
- EV / salestoday's price, trailing year to Jun 30, 2026
- 1.74
- Healthcare median P/E509 names
- 26.2
- Medical Care Facilities median P/E33 names
- 20.0
- Market capitalisation
- $9.69B
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $134.84 |
| Its own P/E history, median | $151.86 |
| Its own P/E history, upper quartile | $170.36 |
| 52-week range | $147.13 – $215.76 |
| Today | $171.78 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.